Browsing Health Sciences Conference Papers by Collaborator "Auckland University of Technology"
Now showing items 1-2 of 2
-
A first New Zealand study looked at the role of lutetium-177-P SMA I &T in the progression of metastatic castrate-resistant prostate cancer
(2021-11)Prostate cancer that has spread beyond the prostate gland and is resistant to castration is a deadly disease that poses a threat to men's health. The current standard of care for metastatic prostate cancer is hormonal ... -
Lutetium-177-PSMA I&T for progressing metastatic castrate-resistant prostate cancer : a single NZ centre experience
(2020-10)Objectives Metastatic Castration resistant prostate cancer (mCRPC) Metastatic Castration resistant prostate cancer (mCRPC) and PSMA Various PSMA ligands and radionuclidessuitable for labelling Lu177-PSMA and Mechanism ...